Union Therapeutics
PrivateLast Round
Convertible Debt
May 1, 2024
Total Funding Raised
$59.17M
Company Overview
Union Therapeutics operates in Healthcare & Life Sciences and is based in Denmark. Its latest recorded funding round was a Convertible Debt round in May 2024.
Union Therapeutics is a clinical-stage pharmaceutical company that identifies, develops, and commercializes treatments for immunology and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Union Therapeutics Comparables
Compare Union Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Newsoara Biopharma Co., Ltd. | 79% | |
| Can Fite Biopharma Ltd ADR | 78% | |
| Aclaris Therapeutics | 77% |
For institutional investors. Book with your work email.
Union Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 1, 2024 | ||||
| Growth Equity | Jul 14, 2023 | ||||
| Private Placement | Dec 1, 2022 | ||||
| Series B | Feb 9, 2021 | ||||
| Debt | Dec 1, 2019 | ||||
Debt | Jan 1, 2018 |
For institutional investors. Book with your work email.
Union Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Board of Directors | Convertible Debt |
| European Investment Bank Group | Debt |
| T&W Medical | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 112% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Union Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Union Therapeutics's valuation, stock price, and market status.
Is Union Therapeutics a public or private company?
Union Therapeutics is a private company.
What is the current stock price of Union Therapeutics?
Union Therapeutics is a private company, so its shares have no public market price. Caplight tracks Union Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Union Therapeutics worth (valuation)?
Valuation information for Union Therapeutics is not publicly available.
Can I buy Union Therapeutics stock?
Union Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Union Therapeutics's last funding round?
Union Therapeutics's most recent funding round was Convertible Debt on May 1, 2024.
Who are the main investors in Union Therapeutics?
Key investors in Union Therapeutics include European Investment Bank Group.
Will Union Therapeutics IPO soon?
No public IPO plans have been announced for Union Therapeutics.
How can I track Union Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Union Therapeutics's shares on secondary markets.